Vincere Biosciences
Boston, United States · Founded 2018 · $5.0M raised
- Headquarters
- Boston
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- vincere.bio
- Total Funding
- $5.0M
- Last Round
- $5.0M SeedNov 2025
- Rounds
- 2
About
Vincere Biosciences is a Boston-based biotechnology company developing small molecule therapeutics that target mitophagy, the process of clearing damaged mitochondria, to treat age-related diseases including Parkinson's disease and kidney disease. Spun out of NeuroInitiative, LLC and launched in October 2018, the company's lead USP30 inhibitor program aims to be a first-in-class, disease-modifying therapeutic, backed by grants and investment from the Michael J. Fox Foundation and the National Institute on Aging.
Summary
Vincere Biosciences is a Biotech company based in Boston, United States, founded in 2018. It has raised $5.0M in total across 2 rounds, most recently a $5.0M Seed round in Nov 2025. Investors include Draper Associates, Alumni Ventures and LongGame.
Funding History
Nov 2025
Sign up to see all 2 rounds
Seed through Grant — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
China's leading blood products manufacturer
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vincere-biosciences"><img src="https://indexed.vc/api/badge/company/vincere-biosciences" alt="Vincere Biosciences on Indexed.vc" width="260" height="76" /></a>